tumor samples; paired adjacent samples; LUAD tumor tissues; resected tumor tissues
BEAS-2B; HCC827; A549
cell line-derived xenograft
proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); cell cycle (promotes); ceRNA regulation (other); other pathway/process (promotes)
RT-qPCR; Clinical Sample Validation; Nuclear-Cytoplasmic Fractionation; RNase R Treatment; Transfection; CCK8; EdU Staining; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Transwell Assay; Wound Healing Assay; ELISA; Western Blot; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); In Vivo Animal Model; IHC (Immunohistochemistry)
Circ-NUP98 might provide a potential new marker for early diagnosis of LUAD and potentially effective targets for LUAD treatment.
circ-NUP98 is up-regulated in LUAD tissues and cell lines and functions as an oncogenic circRNA. Silencing circ-NUP98 suppresses proliferation, migration, invasion, cell-cycle progression, oxidative stress, and xenograft tumor growth while promoting apoptosis. Mechanistically, circ-NUP98 sponges miR-188-3p to relieve repression of CBX1, forming a circ-NUP98/miR-188-3p/CBX1 regulatory axis.
0.8175
Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p.
combined biological and clinical study